tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Metsera, Inc.: Buy Rating Affirmed Amid Promising Clinical Data and Strategic Positioning
PremiumRatingsMetsera, Inc.: Buy Rating Affirmed Amid Promising Clinical Data and Strategic Positioning
2M ago
Metsera initiated with Early-Stage Biotech at Goldman Sachs
Premium
The Fly
Metsera initiated with Early-Stage Biotech at Goldman Sachs
2M ago
Circle initiated, Charter upgraded: Wall Street’s top analyst calls
Premium
The Fly
Circle initiated, Charter upgraded: Wall Street’s top analyst calls
3M ago
Morning Movers: Warner Bros. Discovery climbs after plans to separate
PremiumThe FlyMorning Movers: Warner Bros. Discovery climbs after plans to separate
3M ago
Metsera, Inc. Reports Positive Phase 1 Trial Results
Premium
Company Announcements
Metsera, Inc. Reports Positive Phase 1 Trial Results
3M ago
Metsera announces topline data from Phase 1 trial of MET-233i
Premium
The Fly
Metsera announces topline data from Phase 1 trial of MET-233i
3M ago
Metsera reports Q4 EPS ($3.52) vs. (94c) last year
PremiumThe FlyMetsera reports Q4 EPS ($3.52) vs. (94c) last year
6M ago
Metsera sees cash runway into 2027
Premium
The Fly
Metsera sees cash runway into 2027
6M ago
Metsera, Inc. Approves 2024 Executive Cash Bonuses
Premium
Company Announcements
Metsera, Inc. Approves 2024 Executive Cash Bonuses
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100